Key statistics
As of last trade Neogenomics Inc (NG9:MUN) traded at 8.35, -26.11% below its 52-week high of 11.30, set on Jan 15, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 8.35 |
|---|---|
| High | 8.35 |
| Low | 8.35 |
| Bid | 8.02 |
| Offer | 8.13 |
| Previous close | 8.50 |
| Average volume | 605.86 |
|---|---|
| Shares outstanding | 129.81m |
| Free float | 128.02m |
| P/E (TTM) | -- |
| Market cap | 1.28bn USD |
| EPS (TTM) | -0.844 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 07:04 GMT.
More ▼
- NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
- NeoGenomics to Participate in Upcoming Investor Conferences
- NeoGenomics Reports Fourth Quarter and Full Year 2025 Results
- NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection
- NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
- NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
- NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors
- NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
- NeoGenomics to Present New ctDNA Research at SABCS 2025
More ▼
